Effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-12-19

AUTHORS

Jun Liang, Jianwu Xi, Huijuan Pan, Ying Qian, Dan Xu, Min Li

ABSTRACT

ObjectiveThe aim of this study was to evaluate effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer.MethodsFourteen cases of patients diagnosed with non-small cell lung cancer (NSCLC), the use of the B-, CT-guided, according to preoperative imaging and treatment planning system (TPS) program for radioactive particles interposed 125I interstitial radiotherapy.ResultsAll patients were successfully 125I interstitial radioactive particles interposed radiotherapy. Postoperative local complete tumor remission in 9 cases, partial remission in 5 cases, the efficiency of 100%. No case of serious complications. After 3 to 4 weeks of chemotherapy after 11 cases. 4 cases of lung cancer with bone metastases, pain completely disappeared after treatment. Up to now, five cases have died due to tumor progression, survival time of 12 to 16 months. Nine cases still under follow-up observation and treatment.Conclusion125I radioactive particles interposed radiotherapy between organizations of lung cancer, simple operation, trauma, fewer complications, conformal high, high local tumor dose, efficacy, and is a supplement of modern radiotherapy techniques for the treatment of lung cancer provides a comprehensive line of the method of effective. More... »

PAGES

564-567

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4

DOI

http://dx.doi.org/10.1007/s10330-013-1245-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048045179


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liang", 
        "givenName": "Jun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xi", 
        "givenName": "Jianwu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pan", 
        "givenName": "Huijuan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Qian", 
        "givenName": "Ying", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xu", 
        "givenName": "Dan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Oncology, The People\u2019s Hospital Wuxi Huishan Region, 214187, Wuxi, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Min", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10330-006-0029-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003749079", 
          "https://doi.org/10.1007/s10330-006-0029-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-12-19", 
    "datePublishedReg": "2013-12-19", 
    "description": "ObjectiveThe aim of this study was to evaluate effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer.MethodsFourteen cases of patients diagnosed with non-small cell lung cancer (NSCLC), the use of the B-, CT-guided, according to preoperative imaging and treatment planning system (TPS) program for radioactive particles interposed 125I interstitial radiotherapy.ResultsAll patients were successfully 125I interstitial radioactive particles interposed radiotherapy. Postoperative local complete tumor remission in 9 cases, partial remission in 5 cases, the efficiency of 100%. No case of serious complications. After 3 to 4 weeks of chemotherapy after 11 cases. 4 cases of lung cancer with bone metastases, pain completely disappeared after treatment. Up to now, five cases have died due to tumor progression, survival time of 12 to 16 months. Nine cases still under follow-up observation and treatment.Conclusion125I radioactive particles interposed radiotherapy between organizations of lung cancer, simple operation, trauma, fewer complications, conformal high, high local tumor dose, efficacy, and is a supplement of modern radiotherapy techniques for the treatment of lung cancer provides a comprehensive line of the method of effective.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10330-013-1245-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1032171", 
        "issn": [
          "1610-1979", 
          "1613-9089"
        ], 
        "name": "The Chinese-German Journal of Clinical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "non-small cell lung cancer", 
      "lung cancer", 
      "weeks of chemotherapy", 
      "cell lung cancer", 
      "complete tumor remission", 
      "modern radiotherapy techniques", 
      "MethodsFourteen cases", 
      "ResultsAll patients", 
      "partial remission", 
      "bone metastases", 
      "serious complications", 
      "preoperative imaging", 
      "tumor remission", 
      "interstitial radiotherapy", 
      "tumor dose", 
      "survival time", 
      "radiotherapy techniques", 
      "radiotherapy", 
      "tumor progression", 
      "cancer", 
      "remission", 
      "complications", 
      "patients", 
      "treatment", 
      "radioactive particles", 
      "pain", 
      "chemotherapy", 
      "metastasis", 
      "cases", 
      "follow", 
      "trauma", 
      "dose", 
      "progression", 
      "weeks", 
      "months", 
      "CT", 
      "efficacy", 
      "supplements", 
      "imaging", 
      "effect", 
      "aim", 
      "mechanism", 
      "study", 
      "use", 
      "program", 
      "lines", 
      "organization", 
      "time", 
      "observations", 
      "system program", 
      "technique", 
      "method", 
      "comprehensive line", 
      "operation", 
      "simple operation", 
      "particles", 
      "efficiency"
    ], 
    "name": "Effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer", 
    "pagination": "564-567", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048045179"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10330-013-1245-4"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10330-013-1245-4", 
      "https://app.dimensions.ai/details/publication/pub.1048045179"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:28", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_588.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10330-013-1245-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10330-013-1245-4'


 

This table displays all metadata directly associated to this object as RDF triples.

148 TRIPLES      22 PREDICATES      83 URIs      74 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10330-013-1245-4 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nd66798edb0b84d409a12d4a4e1781656
4 schema:citation sg:pub.10.1007/s10330-006-0029-5
5 schema:datePublished 2013-12-19
6 schema:datePublishedReg 2013-12-19
7 schema:description ObjectiveThe aim of this study was to evaluate effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer.MethodsFourteen cases of patients diagnosed with non-small cell lung cancer (NSCLC), the use of the B-, CT-guided, according to preoperative imaging and treatment planning system (TPS) program for radioactive particles interposed 125I interstitial radiotherapy.ResultsAll patients were successfully 125I interstitial radioactive particles interposed radiotherapy. Postoperative local complete tumor remission in 9 cases, partial remission in 5 cases, the efficiency of 100%. No case of serious complications. After 3 to 4 weeks of chemotherapy after 11 cases. 4 cases of lung cancer with bone metastases, pain completely disappeared after treatment. Up to now, five cases have died due to tumor progression, survival time of 12 to 16 months. Nine cases still under follow-up observation and treatment.Conclusion125I radioactive particles interposed radiotherapy between organizations of lung cancer, simple operation, trauma, fewer complications, conformal high, high local tumor dose, efficacy, and is a supplement of modern radiotherapy techniques for the treatment of lung cancer provides a comprehensive line of the method of effective.
8 schema:genre article
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf Nb2010c4affaf4392a6cdd5ab7c518657
12 Nbd341a9ee6924bc29702901c5cdd3ccc
13 sg:journal.1032171
14 schema:keywords CT
15 MethodsFourteen cases
16 ResultsAll patients
17 aim
18 bone metastases
19 cancer
20 cases
21 cell lung cancer
22 chemotherapy
23 complete tumor remission
24 complications
25 comprehensive line
26 dose
27 effect
28 efficacy
29 efficiency
30 follow
31 imaging
32 interstitial radiotherapy
33 lines
34 lung cancer
35 mechanism
36 metastasis
37 method
38 modern radiotherapy techniques
39 months
40 non-small cell lung cancer
41 observations
42 operation
43 organization
44 pain
45 partial remission
46 particles
47 patients
48 preoperative imaging
49 program
50 progression
51 radioactive particles
52 radiotherapy
53 radiotherapy techniques
54 remission
55 serious complications
56 simple operation
57 study
58 supplements
59 survival time
60 system program
61 technique
62 time
63 trauma
64 treatment
65 tumor dose
66 tumor progression
67 tumor remission
68 use
69 weeks
70 weeks of chemotherapy
71 schema:name Effect and mechanism of 125I radioactive particles interposed radiotherapy between organizations on lung cancer
72 schema:pagination 564-567
73 schema:productId N9d903a7cbb8545689aedc75396c3e0ac
74 Nf250566d6fdf4293ae279e311f7a19d2
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048045179
76 https://doi.org/10.1007/s10330-013-1245-4
77 schema:sdDatePublished 2022-05-20T07:28
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N43a3d8e3253a4e4e939cf0aae15f2676
80 schema:url https://doi.org/10.1007/s10330-013-1245-4
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N21bd4895bb8c4b9dbb2a31be5c7d28bc rdf:first Nc5b86b6df3eb4ed3a5467327a028ebdc
85 rdf:rest rdf:nil
86 N29f8a5d4363248f58c5c2e749495c4f8 rdf:first N965613604882450baa355e649ad149c3
87 rdf:rest N4a186de1f7354d95b952d34fbb873328
88 N43a3d8e3253a4e4e939cf0aae15f2676 schema:name Springer Nature - SN SciGraph project
89 rdf:type schema:Organization
90 N4a186de1f7354d95b952d34fbb873328 rdf:first N953b2c60ce0644ec99b4c92c589b8f4a
91 rdf:rest N7a3d6d0f19184491b66bb610f199776c
92 N4b003d153d644e5a9ec310bef95170dc schema:affiliation grid-institutes:None
93 schema:familyName Liang
94 schema:givenName Jun
95 rdf:type schema:Person
96 N7a3d6d0f19184491b66bb610f199776c rdf:first N8d176c3ef48d465da15ff82ca421f6c7
97 rdf:rest N21bd4895bb8c4b9dbb2a31be5c7d28bc
98 N8d176c3ef48d465da15ff82ca421f6c7 schema:affiliation grid-institutes:None
99 schema:familyName Xu
100 schema:givenName Dan
101 rdf:type schema:Person
102 N953b2c60ce0644ec99b4c92c589b8f4a schema:affiliation grid-institutes:None
103 schema:familyName Qian
104 schema:givenName Ying
105 rdf:type schema:Person
106 N965613604882450baa355e649ad149c3 schema:affiliation grid-institutes:None
107 schema:familyName Pan
108 schema:givenName Huijuan
109 rdf:type schema:Person
110 N9d903a7cbb8545689aedc75396c3e0ac schema:name dimensions_id
111 schema:value pub.1048045179
112 rdf:type schema:PropertyValue
113 Na0c8df5516014b8986f5547301dda4a1 schema:affiliation grid-institutes:None
114 schema:familyName Xi
115 schema:givenName Jianwu
116 rdf:type schema:Person
117 Nb2010c4affaf4392a6cdd5ab7c518657 schema:volumeNumber 12
118 rdf:type schema:PublicationVolume
119 Nbd341a9ee6924bc29702901c5cdd3ccc schema:issueNumber 12
120 rdf:type schema:PublicationIssue
121 Nc5b86b6df3eb4ed3a5467327a028ebdc schema:affiliation grid-institutes:None
122 schema:familyName Li
123 schema:givenName Min
124 rdf:type schema:Person
125 Nd66798edb0b84d409a12d4a4e1781656 rdf:first N4b003d153d644e5a9ec310bef95170dc
126 rdf:rest Nfe4167679d23413d9e13d4a9162f1a8e
127 Nf250566d6fdf4293ae279e311f7a19d2 schema:name doi
128 schema:value 10.1007/s10330-013-1245-4
129 rdf:type schema:PropertyValue
130 Nfe4167679d23413d9e13d4a9162f1a8e rdf:first Na0c8df5516014b8986f5547301dda4a1
131 rdf:rest N29f8a5d4363248f58c5c2e749495c4f8
132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical and Health Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
136 schema:name Oncology and Carcinogenesis
137 rdf:type schema:DefinedTerm
138 sg:journal.1032171 schema:issn 1610-1979
139 1613-9089
140 schema:name The Chinese-German Journal of Clinical Oncology
141 schema:publisher Springer Nature
142 rdf:type schema:Periodical
143 sg:pub.10.1007/s10330-006-0029-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003749079
144 https://doi.org/10.1007/s10330-006-0029-5
145 rdf:type schema:CreativeWork
146 grid-institutes:None schema:alternateName Department of Oncology, The People’s Hospital Wuxi Huishan Region, 214187, Wuxi, China
147 schema:name Department of Oncology, The People’s Hospital Wuxi Huishan Region, 214187, Wuxi, China
148 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...